Relationship between the effector T-cell response and viremia in symptomatic chronic hepatitis C

Archives of Pathology and Laboratory Medicine

Volumn 122, Issue 5, 1998, Pages 416-422

  Mosnier, Jean François ^a,c   Pham, Bach Nga ^a   Scoazec, Jean Yves ^b   Dubois, Sylvie ^a   Marcellin, Patrick ^a   Martinot Peignoux, Michèle ^a   Degos, Françoise ^a   Erlinger, Serge ^a   Degott, Claude ^a  

^a BEAUJON HOSPITAL   (France)

^b INSERM   (France)

^c SERVICE DE NEUROLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HOST RESISTANCE; HUMAN; INFECTION RESISTANCE; LIVER BIOPSY; LYMPHOCYTIC INFILTRATION; MALE; T LYMPHOCYTE ACTIVATION; VIREMIA;

EID: 0031838038     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood borne non-A, non-B hepatitis genome. Science. 1989;244:359-362.
2. Dienstag JL. Non-A, non-B hepatitis, I: recognition, epidemiology, and clinical features. Gastroenterology. 1983;85:439-462.
3. Koretz RL, Stone O, Mousa M, Gitnick GL. Non-A, non-B post transfusion hepatitis: a decade later. Gastroenterology. 1985;88:1251-1254.
4. Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med. 1992;327: 1899-1905.
5. Yano M, Kumada H, Kage M, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology. 1996;23:1334-1340.
6. Alberti A, Morsica G, Chemello L, et al. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet. 1992;340:697-698.
7. Brillanti S, Foli M, Gaiani S, Masci C, Miglioli M, Barbara L. Persistent hepatitis C viraemia without liver disease. Lancet. 1993;341:464-465.
8. Thomas ML, LeFrancois L. Differential expression of the leukocyte-common antigen family. Immunol Today. 1988;9:320.
9. Terry LA, Brown H, Beverley PCL. The monoclonal antibody UCHL 1 recognizes a 180,000 MW component of the human leukocyte-common antigen CD45. Immunology. 1988;64:331-336.
10. Deans JP, Boyd AW, Pilarski LM. Transitions from high to low molecular weight isoforms of CD45 (T200) involve rapid activation of alternate mRNA splicing and slow turnover of surface CD45R. J Immunol. 1989;143:1233-1238.
11. + helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation. J Immunol. 1988;141:1464-1470.
12. Byrne JA, Butler JL, Cooper MD. Differential activation requirement for virgin and memory T cells. J Immunol. 1988;141:3249-3257.
13. + cytotoxic T lymphocytes. J Immunol. 1989;143:1518-1523.
14. Sanders ME, Makgoba MW, Sharrow SO, et al. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2 and LFA-1) and three other molecules (UCHL-1, CDw29 and PgP-1) and have enhanced IFN-gamma production. J Immunol. 1988;140:1401-1407.
15. Merkenschlager M, Terry L, Edwards R, Beverley PCL. Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by the monoclonal antibody UCHL-1: implications for differential CD45 expression in T cell memory formation. Eur J Immunol. 1988;18:1653-1661.
16. + cells with different requirements for activation and differentiation. J Immunol. 1991;146:2088-2094.
17. Montano L, Aranguibel F, Bofill M, Goodall AH, Janossy G, Thomas HC. An analysis of the composition of the inflammatory infiltrate in autoimmune and hepatitis B virus-induced chronic liver disease. Hepatology. 1983;3:292-296.
18. Colucci G, Colombo M, Del Ninno E, Paronetto F. In situ characterization by monoclonal antibodies of the mononuclear cell infiltrate in chronic active hepatitis. Gastroenterology. 1983;85:1138-1145.
19. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431-435.
20. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19:1513-1520.
21. Mason DY, Sammons RE. The labelled antigen method of immunoenzymatic staining. J Histochem Cytochem. 1979;27:832-840.
22. Graham RC Jr, Karnovsky MJ. The early stages of absorption of horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique. J Histochem Cytochem. 1966;14:291-302.
23. Negro F, Pacchioni D, Shimizu Y, et al. Detection of intrahepatic replication of hepatitis C virus RNA by in situ hybridization and comparison with histopathology. Proc Natl Acad Sci USA. 1992;89:2247-2251.
24. Blight K, Trowbridge R, Rowland R, Gowans EJ. Detection of hepatitis C virus RNA by in situ hybridization. Liver. 1992;12:286-289.
25. Lamas E, Baccarini P, Housset C, Kremsdorf D, Bréchot C. Detection of hepatitis C virus (HCV) RNA sequences in liver tissue by in situ hybridization. J Hepatol. 1992;16:219-223.
26. Nouri Aria KT, Sallie R, Sangar D, et al. Detection of genomic and intermediate replicative strands of hepatitis C virus in liver tissue by in situ hybridization. J Clin Invest. 1993;92:2226-2234.
27. Lau GKK, Davis GL, Wu SPC, Gish RG, Balart LA, Lau JYN. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction. Hepatology. 1996;23:1318-1323.
28. Nuovo CJ, Lidonnici K, MacConnell P, Lane B. Intracellular localization of polymerase chain reaction (PCR)-amplified hepatitis C cDNA. Am J Surg Pathol. 1993;17:683-690.
29. Infantilino D, Chiramonte M, Zanetti AR, Lesniewski RR, Bonino F. Localization of hepatitis C virus antigen(s) by immunohistochemistry on fixed-embedded liver tissue. Arch Virol. 1992;4(suppl):191-195.
30. Hiramatsu N, Hayashi N, Haruna Y, et al. Immunohistochemical detection of hepatitis C virus infected hepatocytes in chronic liver disease with monoclonal antibodies to core, envelope and NS3 regions of the hepatitis C virus genome. Hepatology. 1992;16:306-311.
31. Krawczynski K, Beach MJ, Bradley DW, et al. Hepatitis C virus antigen in hepatocytes: immunomorphologic detection and identification. Gastroenterology. 1992;103:622-629.
32. Blight K, Lesniewski RR, LaBrooy JT, Gowans EJ. Detection and distribution of hepatitis C-specific antigens in naturally infected liver. Hepatology. 1994;20:553-557.
33. McGuinness PH, Bishop GA, Painter DM, Chan R, McCaughan GW. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology. 1996;23:676-687.
34. Nagakawa H, Shimomura H, Hasui T, Tsuji H, Tsuji T. Quantitative detection of hepatitis C genome in liver tissue and circulation by competitive reverse transcription-polymerase chain reaction. Dig Dis Sci. 1994;39:225-233.
35. Coelho-Little E, Jeffers LJ, Bartholomew M, Reddy KR, Schiff ER, Dailey PJ. Correlation of HCV-RNA levels in serum and liver of patients with chronic hepatitis C. J Hepatol. 1995;22:248-249.
36. Hayata T, Nakano Y, Yoshizawa K, Sodeyama T, Kiyosawa K. Effects of interferon on intrahepatic human leukocyte antigens and lymphocyte subsets in patients with chronic hepatitis B and C. Hepatology. 1991;13:1022-1028.
37. Koziel MJ, Dudley D, Wong JT, et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol. 1992;149:3339-3344.
38. Koziel MJ, Dudley D, Wong JT, et al. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol. 1993;67:7522-7532.
39. Kita H, Moriyama T, Kaneko T, et al. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein. Hepatology. 1993;18:1039-1044.
40. Mosnier J-F, Scoazec J-Y, Marcellin P, Degott C, Benhamou J-P, Feldmann G. Expression of cytokine-dependent adhesion molecules by hepatocytes and bile duct cells in chronic hepatitis C. Gastroenterology. 1994;107:1457-1468.
41. Ballardini G, Groff P, Pontisso P. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A, B, C and intercellular adhesion-1 molecules: clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C. J Clin Invest. 1995;95:2067-2075.
42. Horiike N, Onji M, Kumon I, Kanaoka M, Michitaka K, Ohta Y. Intercellular adhesion molecule-1 expression on the hepatocyte membrane of patients with chronic hepatitis B and C. Liver. 1993;13:10-14.
43. Thomas HC, Montano L, Goodall A, de Koning R, Oladapo J, Wiedman KH. Immunological mechanisms in chronic hepatitis B virus infection. Hepatology. 1982;2(suppl):116-121.
44. Barnaba V, Balsano F. Immunological and molecular basis of viral persistence: the hepatitis B virus model. J Hepatol. 1992;14:391-400.
45. Bertoletti A, Ferrari C, Fiaccadori F, et al. HLA class 1-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid. Proc Natl Acad Sci U S A. 1991;88:10445-10449.
46. Moriyama T, Guilhot S, Klopchin K, et al. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science. 1990;248:361-364.
47. Gilles PN, Guerette DL, Ulevitch RJ, Schreiber RD, Chisari FV. HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon γ. Hepatology. 1992;16:655-663.
48. Missale G, Redeker A, Person J, et al. HLA-A31 and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med. 1993;117:751-753.
49. Ando K, Guidotti LG, Wirth S, et al. Class 1-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol. 1994; 152:3245-3253.
50. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology. 1992;15:572-577.
51. Lefkowitch JH, Schiff ER, Davis GL, et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. Gastroenterology. 1994;104:595-603.
52. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. Hepatology. 1992;15:567-571.
53. Emile J-F, Sebagh M, Féray C, David F, Reynès M. The presence of epithelioid granulomas in hepatitis C virus-related cirrhosis. Hum Pathol. 1993;24:1095-1097.
54. Freni MA, Artuso D, Gerken G. et al. Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohistochemical characterization, and relation to markers of autoimmunity. Hepatology. 1995;22:389-394.
55. Mosnier J-F, Degott C, Marcellin P, Hénin D, Erlinger S, Benhamou J-P. The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology. 1993;17:366-371.
56. Martinot-Peignoux M, Marcellin P, Pouteau M, et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology. 1995;22:1050-1056.
57. Hopf U, Berg T, König V, Küther S, Heuft H-G, Lobeck H. Treatment of chronic hepatitis C with interferon alpha: long term follow-up and prognostic relevance of HCV genotypes. J Hepatol. 1996;24(suppl):67-73.
58. Conjeevaram HS, Everhart JE, Hoofnagle JH. Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C. Hepatology. 1995;22:1326-1328.